90 related articles for article (PubMed ID: 7003457)
1. Prognosis of primarily treated localized laryngeal carcinoma ameliorated through levamisole treatment: a randomized pilot study.
Mussche RA; Kluyskens P
Oncology; 1980; 37(5):329-35. PubMed ID: 7003457
[TBL] [Abstract][Full Text] [Related]
2. Levamisole versus placebo as an adjunct to primary therapy of laryngopharyngeal epidermoid carcinoma. Evaluation of the immune status.
Mussche RA; Plum J; de Smedt M; Kluyskens P
Acta Otorhinolaryngol Belg; 1977; 31(6):566-77. PubMed ID: 339662
[TBL] [Abstract][Full Text] [Related]
3. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. I. A three-year clinical follow up.
Padmanabhan TK; Balaram P; Vasudevan DM
Neoplasma; 1987; 34(5):627-32. PubMed ID: 3696303
[TBL] [Abstract][Full Text] [Related]
4. Levamisole in squamous cell carcinoma of the head and neck.
Olivari AJ; Glait HM; Guardo A; Califano L; Pradier R
Cancer Treat Rep; 1979 Jun; 63(6):983-90. PubMed ID: 380804
[TBL] [Abstract][Full Text] [Related]
5. Treatment of inoperable non-small cell carcinoma of the lung with radiation therapy, with or without levamisole. A randomized trial of the Southeastern Cancer Study group.
Krauss S; Comas F; Perez C; Gordon D; Philpott G; Broun G; Mill W; Robbins R; Smalley R; Mendiondo O
Am J Clin Oncol; 1984 Oct; 7(5):405-12. PubMed ID: 6391141
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different treatment modalities in advanced laryngeal hypopharyngeal squamous cell carcinoma.
Ghaffar S; Akhtar S; Ikram M; Imam SZ; Sepah YJ
J Coll Physicians Surg Pak; 2010 Mar; 20(3):171-4. PubMed ID: 20392379
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy with levamisole in resectable lung cancer.
Amery WK; Cosemans J; Gooszen HC; Lopes Cardozo E; Louwagie A; Stam J; Swierenga J; Vanderschueren RG; Veldhuizen RW
Recent Results Cancer Res; 1978; 68():268-77. PubMed ID: 379936
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report.
Wanebo HJ; Hilal EY; Pinsky CM; Strong EW; Mike V; Hirshaut Y; Oettgen HF
Cancer Treat Rep; 1978 Nov; 62(11):1663-9. PubMed ID: 365322
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report.
Wanebo HJ; Hilal EY; Strong EW; Pinsky CM; Mike V; Oettgen HF
Recent Results Cancer Res; 1978; 68():324-33. PubMed ID: 379937
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.
Spitler LE; Sagebiel R
N Engl J Med; 1980 Nov; 303(20):1143-7. PubMed ID: 6999349
[TBL] [Abstract][Full Text] [Related]
11. Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma.
Br Med J; 1975 Aug; 3(5981):461-4. PubMed ID: 1098727
[TBL] [Abstract][Full Text] [Related]
12. Final results of a multicenter placebo-controlled levamisole study of resectable lung cancer.
Amery WK
Cancer Treat Rep; 1978 Nov; 62(11):1677-83. PubMed ID: 365323
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
[TBL] [Abstract][Full Text] [Related]
14. Combined laryngeal conservation surgery and irradiation: can we expand the indications for conservation therapy?
Goepfert H; Lindberg RD; Jesse RH
Otolaryngol Head Neck Surg; 1981; 89(6):974-8. PubMed ID: 6801601
[TBL] [Abstract][Full Text] [Related]
15. Limited squamous cell carcinoma of the lung: a Southwest Oncology Group randomized study of radiation with or without doxorubicin chemotherapy and with or without levamisole immunotherapy.
White JE; Chen T; Reed R; Mira J; Stuckey WJ; Weatherall T; O'Bryan R; Samson MK; Seydel HG
Cancer Treat Rep; 1982 May; 66(5):1113-20. PubMed ID: 7044532
[TBL] [Abstract][Full Text] [Related]
16. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. II. Lymphocyte subpopulations.
Balaram P; Padmanabhan TK; Vasudevan DM
Neoplasma; 1988; 35(2):235-42. PubMed ID: 3259681
[TBL] [Abstract][Full Text] [Related]
17. Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.
Wright PW; Hill LD; Peterson AV; Pinkham R; Johnson L; Ivey T; Bernstein I; Bagley C; Anderson R
Cancer Treat Rep; 1978 Nov; 62(11):1671-5. PubMed ID: 215304
[TBL] [Abstract][Full Text] [Related]
18. [The effect of levamisole on non-resected lung cancer--the results of randomized controlled study].
Nishimura M; Morishita M; Urata A; Ota K
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1981-93. PubMed ID: 6307178
[TBL] [Abstract][Full Text] [Related]
19. Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report.
Smith RB; Dekernion J; Baron B; Skinner DG; Kaufman JJ
J Urol; 1978 Mar; 119(3):347-9. PubMed ID: 347106
[TBL] [Abstract][Full Text] [Related]
20. Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.
Quirt IC; Shelley WE; Pater JL; Bodurtha AJ; McCulloch PB; McPherson TA; Paterson AH; Prentice R; Silver HK; Willan AR
J Clin Oncol; 1991 May; 9(5):729-35. PubMed ID: 2016615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
